$NRIS

Norris Industries, Inc. Q1 2026: Revenue $85.01K, Net loss $(161.30K) — 10-Q Summary

Norris Industries reported Q1 2026 revenue of $85.01K, flat year-over-year, and a net loss of $(161.30K), wider than the prior-year quarter's $(151.89K). The company attributes the results to stable production and increased operating costs. Norris is focusing on small fields, EOR technologies, and selective acquisitions to grow reserves and production.

Original reporting
Published Oct 13, 2026, 10:41 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 10:57 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Norris Industries, Inc. Q1 2026: Revenue $85.01K, Net loss $(161.30K) — 10-Q Summary — source image
Decision brief

The 30-second read

$NRISBearishMed
01

Why it matters

The earnings miss is likely to trigger short‑term selling pressure in a low‑liquidity stock.

02

Market read

First‑report earnings for a micro‑cap energy firm; modest negative impact on the stock and sector.

03

What to watch

Reduced capital expenditures and well‑plugging may improve cash flow despite short‑term loss.

Relevance 6/10Novelty 7/10Timing: on filing day

Background

Norris Industries filed its Q1 2026 10‑Q, reporting flat revenue and a deeper loss while outlining cost‑control measures.

Company-level read

Ticker impact

$NRISBearishHigh confidence
Context

Q1 2026 10-Q shows flat revenue $85.01K and widened net loss to $161.30K versus $151.89K a year ago.

Expected impact

downward pressure as market prices in the widened loss

Evidence & confidence

The company posted a larger loss despite stable revenue, indicating deteriorating profitability and may trigger sell‑offs in a thinly‑traded micro‑cap.

Market effects

Oil & gas micro‑cap sector may see modest downside as earnings miss highlights cost pressures.

U.S. small‑cap energy segment could see slight pullback.

Limited; impact confined to niche energy investors.

Counterpoint

If the company successfully executes its EOR and acquisition strategy, the loss may be temporary and the stock could rebound.

Key entities

  • Norris Industries, Inc.

    Micro‑cap oil and gas producer (ticker NRIS).

Related articles

$JNJMedAI 8/10

Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff

Johnson & Johnson (JNJ) stock fell 5% despite raising its full-year outlook due to one-time charges, including talc litigation. Q3 2026 revenue grew 5.9%, but reported net earnings dropped 95.9%. Eli Lilly (LLY) and Pfizer (PFE) also saw declines. JNJ's growth came from its Innovative Medicine division, while MedTech lagged. The company secured market authorization for its OTTAVA robotic surgical system and priority review for RYBREVANT FASPRO.

$JNJHighAI 8/10

Tremfya rescues J&J’s immunology sales to fuel strong Q3

Johnson & Johnson reported Q3 sales of $25.4bn, beating estimates. Tremfya's sales surged 68.3% to $2.4bn, driving a 7.9% increase in the pharma segment. Overall immunology sales grew 1.3%, offset by declines in Stelara, Remicade, and Simponi. J&J raised its 2026 sales and EPS guidance, despite lower Q3 EPS due to acquisitions and legal settlements. Medtech sales grew 2.5%, led by Shockwave's 16.8% increase.

$GSMedAI 8/10

Goldman Sachs Exceeds Q3 Expectations with Strong Revenue Growth

Goldman Sachs reported Q3 EPS of $17.01, beating estimates of $12.86. Revenue rose 23% YoY to $18.68B. Investment banking fees increased 21% to $3.22B, while equities revenue surged 72% to $6.44B. Operating expenses rose 20% to $11.31B, with a $450M charitable contribution reducing EPS by $1.00. CEO David Solomon noted macroeconomic challenges but highlighted U.S. economic resilience and opportunities in M&A and AI infrastructure.